Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA: a cancer journal for clinicians 73. 117–48. https://doi.org/10.3322/caac.21763

Kunovsky L, Tesarikova P, Kala Z, Kroupa R, Kysela P, Dolina J, Trna J (2018) The use of biomarkers in Early Diagnostics of Pancreatic Cancer. Can J Gastroenterol Hepatol 2018:5389820–5389820. https://doi.org/10.1155/2018/5389820

Article  PubMed  PubMed Central  Google Scholar 

Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A (2023) Pancreatic cancer: advances and challenges. Cell 186(8):1729–1754. https://doi.org/10.1016/j.cell.2023.02.014

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sarantis P, Koustas E, Papadimitropoulou A, Papavassiliou AG, Karamouzis MV (2020) Pancreatic ductal adenocarcinoma: treatment hurdles, tumor microenvironment and immunotherapy. World J Gastrointest Oncol 12(2):173–181. https://doi.org/10.4251/wjgo.v12.i2.173

Article  PubMed  PubMed Central  Google Scholar 

Capula M, Peran M, Xu G, Donati V, Yee D, Gregori A, Assaraf YG, Giovannetti E, Deng D (2022) Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance. Drug Resist Updat 64:100864. https://doi.org/10.1016/j.drup.2022.100864

Article  PubMed  CAS  Google Scholar 

Rebelo R, Xavier CPR, Giovannetti E, Vasconcelos MH (2023) Fibroblasts in pancreatic cancer: molecular and clinical perspectives. Trends Mol Med. https://doi.org/10.1016/j.molmed.2023.03.002

Article  PubMed  Google Scholar 

Adamska A, Domenichini A, Falasca M (2017) Pancreatic ductal adenocarcinoma: current and evolving therapies. Int J Mol Sci 18(7):1338. https://doi.org/10.3390/ijms18071338

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vogl UM, Andalibi H, Klaus A, Vormittag L, Schima W, Heinrich B, Kafka A, Winkler T, Öhler L (2019) Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter? BMC Cancer 19(1):28–28. https://doi.org/10.1186/s12885-018-5240-6

Article  PubMed  PubMed Central  Google Scholar 

Xavier CPR, Castro I, Caires HR, Ferreira D, Cavadas B, Pereira L, Santos LL, Oliveira MJ, Vasconcelos MH (2021) Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine. Cancer Lett 501:210–223. https://doi.org/10.1016/j.canlet.2020.11.013

Article  PubMed  CAS  Google Scholar 

Chen IM, Johansen AZ, Dehlendorff C, Jensen BV, Bojesen SE, Pfeiffer P, Bjerregaard JK, Nielsen SE, Andersen F, Hollander NH, Yilmaz MK, Rasmussen LS, Johansen JS (2020) Prognostic value of combined detection of serum IL6, YKL-40, and C-reactive protein in patients with unresectable pancreatic Cancer. Cancer Epidemiol Biomarkers Prev 29(1):176–184. https://doi.org/10.1158/1055-9965.EPI-19-0672

Article  PubMed  CAS  Google Scholar 

Chen HT, Zheng JM, Zhang YZ, Yang M, Wang YL, Man XH, Chen Y, Cai QC, Li ZS (2017) Overexpression of YKL-40 predicts poor prognosis in patients undergoing curative resection of pancreatic Cancer. Pancreas 46(3):323–334. https://doi.org/10.1097/MPA.0000000000000751

Article  PubMed  CAS  Google Scholar 

Yu JE, Yeo IJ, Han SB, Yun J, Kim B, Yong YJ, Lim YS, Kim TH, Son DJ, Hong JT (2024) Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer. Exp Mol Med 56(1):1–18. https://doi.org/10.1038/s12276-023-01131-9

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chang MC, Chen CT, Chiang PF, Chiang YC (2024) The role of Chitinase-3-like Protein-1 (YKL40) in the therapy of Cancer and other chronic-inflammation-related diseases. Pharmaceuticals (Basel) 17(3). https://doi.org/10.3390/ph17030307

Zhao T, Su Z, Li Y, Zhang X, You Q (2020) Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther 5(1):201. https://doi.org/10.1038/s41392-020-00303-7

Article  PubMed  PubMed Central  CAS  Google Scholar 

Di Rosa M, Distefano G, Zorena K, Malaguarnera L (2016) Chitinases and immunity: ancestral molecules with new functions. Immunobiology 221(3):399–411. https://doi.org/10.1016/j.imbio.2015.11.014

Article  PubMed  CAS  Google Scholar 

Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268(34):25803–25810

Article  PubMed  CAS  Google Scholar 

Renkema GH, Boot RG, Au FL, Donker-Koopman WE, Strijland A, Muijsers AO, Hrebicek M, Aerts JM (1998) Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 251(1–2):504–509. https://doi.org/10.1046/j.1432-1327.1998.2510504.x

Article  PubMed  CAS  Google Scholar 

Fusetti F, Pijning T, Kalk KH, Bos E, Dijkstra BW (2003) Crystal structure of human cartilage gp39 (HC-gp39) in complex with chitotetraose. https://www.rcsb.org/structure/1NWU

Houston DR, Recklies AD, Krupa JC, van Aalten DM (2003) Structure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes. J Biol Chem 278(32):30206–30212. https://doi.org/10.1074/jbc.M303371200

Article  PubMed  CAS  Google Scholar 

Fusetti F, Pijning T, Kalk KH, Bos E, Dijkstra BW (2003) Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39. J Biol Chem 278(39):37753–37760. https://doi.org/10.1074/jbc.M303137200

Article  PubMed  CAS  Google Scholar 

Rebelo R, Polónia B, Santos LL, Vasconcelos MH, Xavier CPR (2021) Drug Repurposing opportunities in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals (Basel) 14(3):280

Article  PubMed  CAS  Google Scholar 

Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ (2016) Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc 11(5):905–919. https://doi.org/10.1038/nprot.2016.051

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46(D1):D1074–d1082. https://doi.org/10.1093/nar/gkx1037

Article  PubMed  CAS  Google Scholar 

Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455–461. https://doi.org/10.1002/jcc.21334

Article  PubMed  PubMed Central  CAS  Google Scholar 

Seeliger D, de Groot BL (2010) Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des 24(5):417–422. https://doi.org/10.1007/s10822-010-9352-6

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lill MA, Danielson ML (2011) Computer-aided drug design platform using PyMOL. J Comput Aided Mol Des 25(1):13–19. https://doi.org/10.1007/s10822-010-9395-8

Article  PubMed  CAS  Google Scholar 

Branco H, Oliveira J, Antunes C, Santos LL, Vasconcelos MH, Xavier CPR (2022) Pirfenidone sensitizes NCI-H460 Non-small Cell Lung Cancer cells to Paclitaxel and to a combination of Paclitaxel with Carboplatin. Int J Mol Sci 23(7). https://doi.org/10.3390/ijms23073631

Rovithi M, Avan A, Funel N, Leon LG, Gomez VE, Wurdinger T, Griffioen AW, Verheul HM, Giovannetti E (2017) Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing. Sci Rep 7:44686. https://doi.org/10.1038/srep44686

Article  PubMed  PubMed Central  Google Scholar 

Silva BR, Rebelo R, Rodrigues JM, Xavier CPR, Vasconcelos MH, Queiroz MRP (2021) Synthesis of Novel Methyl 3-(hetero)arylthieno[3,2-b]pyridine-2-carboxylates and antitumor activity evaluation: studies in Vitro and in Ovo grafts of Chick Chorioallantoic membrane (CAM) with a Triple negative breast Cancer Cell line. Molecules 26(6). https://doi.org/10.3390/molecules26061594

Vichai V, Kirtikara K (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1(3):1112–1116. https://doi.org/10.1038/nprot.2006.179

Article  PubMed